BiotechTube
Home/Certa Therapeutics/Simona Carbone
SC

Simona Carbone

Director of Business Development and Operations

Certa Therapeutics

Therapeutic Areas

FibrosisNephrology

Certa Therapeutics Pipeline

DrugIndicationPhase
FT011 (asengeprast)Systemic sclerosis (scleroderma)Phase 2
FT012Chronic kidney diseasePreclinical
FT013Diabetic nephropathyPreclinical
FT014Focal segmental glomerulosclerosisPreclinical

Leadership Team at Certa Therapeutics

DK
Darren Kelly
CEO / Managing Director
TM
Tom Mathers
Vice Chairman
MP
Michelle Papadimitriou
Research and Development Director
View full Certa Therapeutics profile